Protective effects of mitochondrion-targeted peptide SS-31 against hind limb ischemia-reperfusion injury

Area of Science:

• Vascular Surgery
• Mitochondrial Medicine
• Oxidative Stress Research

Background:

• Hind limb ischemia-reperfusion (IR) injury is a significant concern in vascular surgery.
• Reactive oxygen species (ROS) play a key role in the pathogenesis of IR injury.
• SS-31, a mitochondrion-targeted peptide antioxidant, effectively reduces mitochondrial ROS production.

Purpose of the Study:

• To investigate the protective effects of SS-31 against hind limb IR injury in a mouse model.
• To determine if SS-31 administration before or after ischemia influences its protective efficacy.
• To elucidate the underlying mechanisms of SS-31's protective action.

Main Methods:

• A mouse model of hind limb ischemia-reperfusion injury was established.
• Mice were treated with SS-31 either before or after the ischemic period.
• Histopathological analysis, oxidative stress markers (malondialdehyde, Sod, catalase), cellular ATP content, mitochondrial membrane potential, inflammatory factors (Tnf-α, Il-1β), and apoptosis markers (cytosolic cytC, cleaved-caspase 3) were assessed.

Main Results:

• SS-31 treatment, both before and after ischemia, significantly protected the hind limb from IR-induced damage.
• SS-31 diminished oxidative stress, preserved cellular ATP levels, and maintained mitochondrial membrane potential.
• SS-31 reduced inflammatory responses and inhibited apoptosis by decreasing cytosolic cytochrome c and cleaved-caspase 3 levels.

Conclusions:

• SS-31 demonstrates significant protective effects against hind limb IR injury in mice, acting both preventatively and therapeutically.
• The protective mechanisms involve mitigating oxidative stress, preserving mitochondrial function, and suppressing inflammation and apoptosis.
• SS-31 administration before ischemia showed a slightly greater protective effect than post-ischemia treatment.